Maternal Diabetes Driving Congenital Heart Disease Market Growth: A Significant Driver Propelling The Congenital Heart Disease (CHD) Market In 2025

The Congenital Heart Disease (CHD) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Congenital Heart Disease (CHD) Market Size and Projected Growth Rate?
The congenital heart disease (CHD) market will increase from $4.42 billion in 2024 to $4.87 billion in 2025, growing at a CAGR of 10.1%. The growth is attributed to the higher prevalence of risk factors like obesity and smoking, better diagnostic technologies, an expanding geriatric population, awareness campaigns, improved reimbursement policies, and increased research investments.

The congenital heart disease (CHD) market is forecast to grow to $7.05 billion by 2029, at a CAGR of 9.7%. Growth drivers include expanding healthcare access in developing regions, innovation in cardiac imaging, increased awareness, rising healthcare spending, and personalized medicine. Trends include minimally invasive surgeries, telemedicine for remote consultations, personalized treatments, advanced implantable devices, and AI/ML integration in diagnostics.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15545

What Are the Major Segments in the Congenital Heart Disease (CHD) Market?
The congenital heart disease (CHD) market covered in this report is segmented -

1) By Type: Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types
2) By Diagnosis: Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis
3) By Treatment: Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications
4) By Age Group: Infants, Children, Adolescents, Adults
5) By Application: Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions

Subsegments:
1) By Heart Valve Defects: Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation
2) By Heart Wall Defects: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF)
3) By Blood Vessel Defects: Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus
4) By Other Types: Single Ventricle Defects, Ebstein's Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15545&type=smp

What Are The Driving Congenital Heart Disease (CHD) Market Evolution?
The increase in maternal diabetes cases is expected to promote the growth of the congenital heart disease (CHD) market. Maternal diabetes, which occurs during pregnancy, can lead to congenital heart disease in infants. Rising obesity rates, sedentary lifestyles, and unhealthy diets among women contribute to this increase. The elevated glucose levels in mothers can disrupt fetal heart development, increasing the risk of CHD. According to the National Health Service in October 2023, the adverse pregnancy outcomes among women diagnosed with type 2 diabetes rose from 4.9% in 2021 to 6.6% in 2022. Thus, the increase in maternal diabetes cases is driving the CHD market.

Which Firms Dominate The Congenital Heart Disease (CHD) Market Segments?
Major companies operating in the congenital heart disease (CHD) market are Pfizer Inc., AstraZeneca Plc, Abbott Laboratories, Novartis AG, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Neusoft Corp., Carestream Health, Midmark Corporation, Contec Medical Systems, Randox Laboratories Ltd., Schiller AG, BPL Medical Technologies, Compumedics Limited, Biocare Medical, Bionet America Inc., Nasan Medical Electronics Pvt Ltd

What Are the Major Trends Shaping the Congenital Heart Disease (CHD) Market?
Companies in the congenital heart disease market are focused on developing non-surgical heart valves to improve patient outcomes. For example, in February 2023, Medtronic, a US-based medical technology company, reintroduced its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive solution for patients with right ventricular outflow tract anomalies, offering an alternative to traditional open-heart surgery.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/congenital-heart-disease-chd-global-market-report

Which Is The Largest Region In The Congenital Heart Disease (CHD) Market?
North America was the largest region in the congenital heart disease (CHD) market in 2023. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Congenital Heart Disease (CHD) Market?
2. What is the CAGR expected in the Congenital Heart Disease (CHD) Market?
3. What Are the Key Innovations Transforming the Congenital Heart Disease (CHD) Industry?
4. Which Region Is Leading the Congenital Heart Disease (CHD) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.